Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM03VXN)

Drug Name

N-(4-methylthiazol-2-yl)-2-phenylacetamide Drug Info

Synonyms

N-(4-methylthiazol-2-yl)-2-phenylacetamide; 91392-19-7; N-(4-methyl-1,3-thiazol-2-yl)-2-phenylacetamide; AC1LIKML; CHEMBL388116; MolPort-000-563-422; ZINC563269; AKOS001315153; MCULE-5254964555; ST50771861; N-(4-methylthiazol-2-yl)-2-phenyl-acetamide; N-(4-methyl(1,3-thiazol-2-yl))-2-phenylacetamide

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 956653
TTD Drug ID: DM03VXN

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
LOX-5 messenger RNA (ALOX5 mRNA)	TTSJ6Q4	LOX5_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	4.966	5.133	5.358	6.128

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	9.43E-03	0.14	0.28

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6.